Gilead Sciences is a research-based biopharmaceutical company developing and commercializing medicines founded in 1987 by Michael L. Riordan.
EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs.
Olema Pharmaceuticals is a company founded in 2007 by Cyrus Harmon.